英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
diffuso查看　diffuso　在百度字典中的解释百度英翻中〔查看〕
diffuso查看　diffuso　在Google字典中的解释Google英翻中〔查看〕
diffuso查看　diffuso　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Package Insert - ADSTILADRIN
    ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy designed to deliver a copy of a gene encoding a human interferon-alfa 2b (IFNα2b) to the bladder urothelium
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
    ADSTILADRIN® is the first and only FDA-approved intravesical gene therapy for patients with high-risk BCG-unresponsive NMIBC See Important Safety Info
  • Adstiladrin: Uses, Dosage, Side Effects Warnings - Drugs. com
    Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer Includes Adstiladrin side effects, interactions and indications
  • Nadofaragene firadenovec - Wikipedia
    Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer [1][3][4] It is a non-replicating (cannot multiply in human cells) adenoviral vector-based gene therapy
  • Nadofaragene firadenovec-vncg (urinary bladder route)
    Description Nadofaragene Firadenovec-vncg is used to treat patients with high-risk Bacillus Calmette-Guerin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with a tumor type called carcinoma in situ (CIS) with or without papillary tumors This medicine is to be used only by or under the direct supervision of a doctor
  • Mechanism of action of nadofaragene firadenovec-vncg - PMC
    Effective bladder-preserving therapeutic options are needed for patients with bacillus Calmette-Guérin unresponsive non–muscle-invasive bladder cancer Nadofaragene firadenovec-vncg (Adstiladrin®) was approved by the US Food and Drug Administration
  • Nadofaragene Firadenovec-vncg - NCI - National Cancer Institute
    This page contains brief information about nadofaragene firadenovec-vncg and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials
  • Package Insert - ADSTILADRIN
    ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors
  • Dosing | ADSTILADRIN® (nadofaragene firadenovec-vncg)
    Find information on the dosing and administration of ADSTILADRIN®, including instillation details See Important Safety Info
  • Nadofaragene firadenovec-vncg (ADSTILADRIN) National Drug . . .
    Description Mechanism of Action • Nadofaragene firadenovec is a non-replicating adenoviral vector-based gene therapy for bladder instillation The replication-deficient adenovirus vector contains a transgene encoding the human interferon alfa-2b (IFNα2b) It delivers a copy of the gene encoding IFNα2b to the bladder urothelium resulting in local expression of the IFNα2b protein for anti





中文字典-英文字典  2005-2009